Phytomedicinal Role of Pithecellobium dulce against CCl₄-mediated Hepatic Oxidative Impairments and Necrotic Cell Death

Table 3

Ratio of the liver weight to the body weight and the activities of the serum marker enzymes related to hepatic dysfunction.

Animal groups	Ratio of the liver weight to the body weight (%)	Activities of the serum marker enzymes
		ALT	ALP
Vehicle	4.78 ± 0.26(a)	46.22 ± 2.42(a)	25.88 ± 1.32(a)
AEPD	4.72 ± 0.25(a)	49.15 ± 2.47(a)	28.95 ± 1.28(a)
CCl4	3.33 ± 0.18(b)	97.39 ± 4.88(b)	75.77 ± 3.82(b)
AEPD + CCl4	4.45 ± 0.24(a)	54.58 ± 2.75(a)	52.98 ± 2.66(c)
CCl4 + AEPD	4.29 ± 0.26(a)	62.37 ± 3.12(a)	55.29 ± 2.77(c)
VitC + CCl4	4.55 ± 0.29(a)	50.49 ± 2.55(a)	44.15 ± 2.22(c)
Recovery	3.65 ± 0.17(b)	87.31 ± 4.39(b)	70.56 ± 3.55(b)

ALT: IU l⁻¹ and ALP: KA. Data are mean ± SD, for six animals per group and were analyzed by one-way ANOVA, with Student-Newman-Keuls post hoc tests. Differences were attributed at P < .05, and homogeneous subgroups share common superscripted letters.